Andrea(Flynn)FransonMDMS(She/Her)
Pediatric Hematology & Oncology • Ann Arbor, MIProgram Director, Pediatric Hematology/Oncology Fellowship
Dr. Franson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E Medical Center Dr
Ann Arbor, MI 48109Phone+1 734-936-4000
Summary
- Dr. Andrea Franson is a pediatric hematologist/oncologist in Ann Arbor, MI and is affiliated with Michigan Medicine. She received her medical degree from University of Michigan Medical School and did pediatric and pediatric hematology/oncology training at the Children's Hospital of Philadelphia. She is experienced in neuro-oncology and early-phase clinical trials.
Education & Training
Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 2014 - 2017- Children's Hospital of PhiladelphiaResidency, Pediatrics, 2011 - 2014
University of Michigan Medical SchoolClass of 2011
Certifications & Licensure
MI State Medical License 2019 - 2026
PA State Medical License 2011 - 2021- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial Start of enrollment: 2021 May 03
- ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors Start of enrollment: 2021 Aug 23
- Distress in the Pediatric Oncology Setting: Intervention Versus Natural Adaptation Start of enrollment: 2020 Sep 18
- Join now to see all
Publications & Presentations
PubMed
- Retrospective Comparison of Targeted Anticancer Drugs Predicted by the CNS-TAP Tool Versus Those Selected by a Molecularly Driven Tumor Board in Children With DIPG.Holly J Roberts, Karthik Ravi, Bernard L Marini, Allison Schepers, Cassie Kline
Journal of Pediatric Hematology/oncology. 2024-11-06 - Long-Term Tumor Stability After First-Line Treatment With Larotrectinib in an Infant With NTRK2 Fusion-Positive High-Grade Glioma.Jillian Simoneau, Patricia Robertson, Karin Muraszko, Cormac O Maher, Hugh Garton
Journal of the National Comprehensive Cancer Network. 2024-09-01 - 1 citationsInfluence of socioeconomic status on clinical outcomes of diffuse midline glioma and diffuse intrinsic pontine glioma.John H Lee, Katherine G Holste, Momodou G Bah, Andrea T Franson, Hugh J L Garton
Journal of Neurosurgery. Pediatrics. 2024-06-01
Press Mentions
A Novel ATXN1-DUX4 Fusion Expands the Spectrum of ‘CIC-Rearranged Sarcoma’ of the CNS to Include Non-CIC AlterationsFebruary 7th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
